Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
BVF 13.88M $49.54M Sept. 30, 2014
Deerfield Management Company 12.21M $43.57M Sept. 30, 2014
FMR 11.45M $40.89M Sept. 30, 2014
T. Rowe Price Associates 8.87M $40.47M June 30, 2014
Redmile 8.34M $29.78M Sept. 30, 2014
OrbiMed Advisors 6.40M $22.86M Sept. 30, 2014
STATE STREET CORPORATION 6.33M $22.61M Sept. 30, 2014
BlackRock Fund Advisors 4.65M $16.59M Sept. 30, 2014
Vanguard 3.95M $14.11M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 3.95M $14.09M Sept. 30, 2014
TimesSquare Capital Management 3.94M $14.07M Sept. 30, 2014
Gail Mannix 3.73M $13.31M Sept. 30, 2014
Apex Capital 3.10M $11.07M Sept. 30, 2014
Artal Group S.A. 3.00M $10.71M Sept. 30, 2014
QVT Financial 2.39M $8.54M Sept. 30, 2014
GMT Capital 2.31M $14.38M Sept. 30, 2013
KOPP FUNDS 2.23M $11.17M Dec. 31, 2013
Balyasny Asset Management 2.07M $9.73M March 31, 2014
Kopp Investment Advisors 2.01M $7.16M Sept. 30, 2014
Ulys 2.00M $6.80M March 31, 2012

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M